Literature DB >> 7924141

The mesengenic process.

A I Caplan1.   

Abstract

The genesis of mesodermal tissues, such as bone, cartilage, muscle, marrow stoma, tendon, fat, dermis, and connective tissues, in either embryos or adult organisms is referred to as the mesengenic process. The process is involved in the continual rejuvenation of each mesenchymal tissue and provides a logic for understanding the rapid repair of tissue injuries. The isolation and identification of mesenchymal stem cells and their quantity and distribution allow a better understanding of the turnover and repair motifs used in adult organisms. Mesenchymal stem cells undergo proliferative and commitment events, and their progeny enter discrete lineages that result in the ultimate terminal differentiation of definitive phenotypes such as osteoblasts, chondrocytes, or myoblasts. The molecular and cellular control of the mesengenic process provides a logic for designing cell therapies for the reconstruction of mesenchymal tissues.

Entities:  

Mesh:

Year:  1994        PMID: 7924141

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  116 in total

Review 1.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Metabolic and histological analysis of mesenchymal stem cells grown in 3-D hyaluronan-based scaffolds.

Authors:  N P Rhodes; J K Srivastava; R F Smith; C Longinotti
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

Review 3.  Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells.

Authors:  Lauren S Sherman; Jessian Munoz; Shyam A Patel; Meneka A Dave; Ilani Paige; Pranela Rameshwar
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

4.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Authors:  Ulrich Lindner; Jan Kramer; Jürgen Rohwedel; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

5.  Temporal evolution of skeletal regenerated tissue: what can mechanical investigation add to biological?

Authors:  Remy Casanova; Didier Moukoko; Martine Pithioux; Cyril Pailler-Mattéi; Hassan Zahouani; Patrick Chabrand
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

Review 6.  The stem cell niche should be a key issue for cell therapy in regenerative medicine.

Authors:  José Becerra; Leonor Santos-Ruiz; José A Andrades; Manuel Marí-Beffa
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

7.  Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC).

Authors:  Igor B Resnick; Claudine Barkats; Michael Y Shapira; Polina Stepensky; Allan I Bloom; Avichai Shimoni; David Mankuta; Nira Varda-Bloom; Lyudmila Rheingold; Moshe Yeshurun; Bella Bielorai; Amos Toren; Tsila Zuckerman; Arnon Nagler; Reuven Or
Journal:  Am J Blood Res       Date:  2013-08-19

8.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.

Authors:  Jessica L Lo Surdo; Bryan A Millis; Steven R Bauer
Journal:  Cytotherapy       Date:  2013-08-29       Impact factor: 5.414

9.  Repopulation of intrasynovial flexor tendon allograft with bone marrow stromal cells: an ex vivo model.

Authors:  Yasuhiro Ozasa; Peter C Amadio; Andrew R Thoreson; Kai-Nan An; Chunfeng Zhao
Journal:  Tissue Eng Part A       Date:  2013-11-21       Impact factor: 3.845

10.  The effects of growth and differentiation factor 5 on bone marrow stromal cell transplants in an in vitro tendon healing model.

Authors:  M Hayashi; C Zhao; K-N An; P C Amadio
Journal:  J Hand Surg Eur Vol       Date:  2011-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.